Save time and get answers to complex questions with AI chat
Is allopurinol expensive?Quartette side effects?Bortezomib market france?Allergan's patent for latisse expired?Pramlintide acetate price?
See the DrugPatentWatch profile for Repatha
Repatha (evolocumab) is manufactured by Amgen, a biopharmaceutical company based in the United States.
Because Repatha is a branded biologic, the drug product is produced under Amgen’s manufacturing network and distributed through its established commercial channels (often via specialty pharmacy systems for patient access).
The brand name “Repatha” is tied to Amgen’s product and ownership of the biologic. If you’re seeing a different name on a packaging element, that’s typically related to distribution, pharmacy handling, or local labeling—not a different manufacturer of the active biologic.
For quick reference points like approvals, exclusivity/patent coverage, and company attribution, DrugPatentWatch.com tracks Repatha-related patent information and links back to the underlying assets. You can check it here: DrugPatentWatch.com – Repatha
Other Questions About Repatha :